UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients

Journal of antimicrobial chemotherapy, 2004-01, Vol.53 (1), p.4-9

2004

Link zum Volltext

Verfügbarkeit prüfen

Characterization of oral immune cells in birch pollen‐allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen‐presenting cells

Allergy (Copenhagen), 2015-04, Vol.70 (4), p.408-419

2015

Link zum Volltext

Verfügbarkeit prüfen

Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2017-07, Vol.15 (7), p.1448-1452

2017

Link zum Volltext

Verfügbarkeit prüfen

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis

Clinical and experimental allergy, 2013-05, Vol.43 (5), p.568-577

2013

Link zum Volltext

Verfügbarkeit prüfen

Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate—Severe Allergic Asthma

Clinical pediatrics, 2009-10, Vol.48 (8), p.859-865

2009

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy

Clinical and experimental allergy, 2013-12, Vol.43 (12), p.1362-1373

2013

Link zum Volltext

Verfügbarkeit prüfen

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

The New England journal of medicine, 2019-01, Vol.380 (4), p.335-346

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

Pulmonary pharmacology & therapeutics, 2010-10, Vol.23 (5), p.438-444

2010

Link zum Volltext

Verfügbarkeit prüfen

Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults

Journal of acquired immune deficiency syndromes (1999), 2002-12, Vol.31 (5), p.478

2002

Link zum Volltext

Verfügbarkeit prüfen

C36 ASTHMA THERAPY II: Safety And Tolerability Of Sublingual Tablets Of House Dust Mite Allergen Extracts: A Phase I Study In Adults With House Dust Mite-Associated Allergic Asthma

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Link zum Volltext

Verfügbarkeit prüfen

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial

Clinical therapeutics, 2001-08, Vol.23 (8), p.1166-1179

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficacité des comprimés sublinguaux d’extraits allergéniques acariens dans le traitement de la rhinite allergique aux acariens : évaluation en chambre d’exposition environnementale

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.387-387

2013

Link zum Volltext

Verfügbarkeit prüfen

Délai d’action des comprimés sublinguaux d’extraits allergéniques acariens chez l’adulte

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.389-389

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacité d’un comprimé sublingual de pollens de cinq graminées mesurée par un score combiné journalier : résultats de trois études en exposition naturelle

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.389-389

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacité d’une immunothérapie sublinguale d’extrait de pollen de bouleau 300IR chez l’adulte

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.389

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacité d’une immunothérapie sublinguale d’extrait de pollen de bouleau 300 IR chez l’adulte

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.389-389

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacité d’un comprimé sublingual de pollens de cinq graminées chez les patients mono- et polysensibilisés : analyse des données poolées de quatre études cliniques

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.387-387

2013

Link zum Volltext

Verfügbarkeit prüfen

Hétérogénéité des réponses anticorps chez les patients présentant une amélioration des symptômes au cours de l’immunothérapie allergénique sublinguale

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.359-359

2013

Link zum Volltext

Verfügbarkeit prüfen

Two Year Follow-Up of Patients with Chronic Autoimmune Urticaria Treated with Omalizumab

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB67-AB67

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Chronic Autoimmune Urticaria with Omalizumab

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S226-S227

2008

Link zum Volltext

Verfügbarkeit prüfen

Baseline Allergic Co-morbidities and Aeroallergen Sensitivities in an Observational Study of Children with Moderate-to-Severe Inadequately Controlled Allergic Asthma - The BUS Study

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB65-AB65

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity

Annals of allergy, asthma, & immunology, 2006, Vol.96 (1), p.60-68

2006

Link zum Volltext

Verfügbarkeit prüfen

Addition of Omalizumab Improves Quality of Life in Moderate-Severe Asthmatics Receiving Fluticasone 500 [mu]g/Salmeterol 50 [mu]g

Journal of allergy and clinical immunology, 2007-01, Vol.119 (1), p.S4

2007

Link zum Volltext

Verfügbarkeit prüfen

Addition of Omalizumab Reduces School Absenteeism in Children with Moderate-Severe Persistent Asthma

Journal of allergy and clinical immunology, 2007, Vol.119 (1), p.S150-S150

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma

Journal of allergy and clinical immunology, 2007, Vol.119 (1), p.S10-S10

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(71)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(40)
Humans
(36)
Male
(26)
Female
(23)
Middle Aged
(18)
Adult
(16)
Animals
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(13)
Aged
(12)
Biochemistry & Molecular Biology
(9)
Cytochrome P-450 Enzyme System - Metabolism
(9)
Drug Therapy
(9)
Mice
(9)
Pharmacology
(9)
Rats
(9)
Adolescent
(8)
Immunohistochemistry
(8)
Immunology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients

Characterization of oral immune cells in birch pollen‐allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen‐presenting cells

Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis

Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate—Severe Allergic Asthma

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults

C36 ASTHMA THERAPY II: Safety And Tolerability Of Sublingual Tablets Of House Dust Mite Allergen Extracts: A Phase I Study In Adults With House Dust Mite-Associated Allergic Asthma

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial

Efficacité des comprimés sublinguaux d’extraits allergéniques acariens dans le traitement de la rhinite allergique aux acariens : évaluation en chambre d’exposition environnementale

Délai d’action des comprimés sublinguaux d’extraits allergéniques acariens chez l’adulte

Efficacité d’un comprimé sublingual de pollens de cinq graminées mesurée par un score combiné journalier : résultats de trois études en exposition naturelle

Efficacité d’une immunothérapie sublinguale d’extrait de pollen de bouleau 300IR chez l’adulte

Efficacité d’une immunothérapie sublinguale d’extrait de pollen de bouleau 300 IR chez l’adulte

Efficacité d’un comprimé sublingual de pollens de cinq graminées chez les patients mono- et polysensibilisés : analyse des données poolées de quatre études cliniques

Hétérogénéité des réponses anticorps chez les patients présentant une amélioration des symptômes au cours de l’immunothérapie allergénique sublinguale

Two Year Follow-Up of Patients with Chronic Autoimmune Urticaria Treated with Omalizumab

Treatment of Chronic Autoimmune Urticaria with Omalizumab

Baseline Allergic Co-morbidities and Aeroallergen Sensitivities in an Observational Study of Children with Moderate-to-Severe Inadequately Controlled Allergic Asthma - The BUS Study

Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity

Addition of Omalizumab Improves Quality of Life in Moderate-Severe Asthmatics Receiving Fluticasone 500 [mu]g/Salmeterol 50 [mu]g

Addition of Omalizumab Reduces School Absenteeism in Children with Moderate-Severe Persistent Asthma

Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma

Suchergebnisse filtern